>
New covid-19 guidance from CDC focuses on individual decisions
Corona-Warn-App: Vaccination status will be recognizable by color
Interest-free loans to be rolled out in UK to help with food bills
China to send troops to Russia for 'Vostok' exercise
What's EASIER? MILKING a MINI COW or FULL SIZED COW?
Fully Charged Checks Out Aptera, Drives The Three-Wheeler Solar EV
This Man Built His Own ISP. Now He's Getting $2.6M to Expand It
Blowhole wave energy generator exceeds expectations in 12-month test
3-wheeled EV commuter equals 230 MPGe, blends torque & safety
Starlink Wins FCC Approval For In-Motion Use On Airplanes And Cruise Ships
Raspberry Pi Foundation brings Wi-Fi to Pico microcontroller
Have You Changed Phones Yet?, + Q&A
Breakthrough Zero-Carbon Fertilizer Set to Take Root Across the World as 'Biochar'
Artificial Photosynthesis Can Produce More Food in the Dark Than With Sunshine
Scientists at University College London (UCL) have demonstrated in rodents a new type of "micromagnet" that can work as a miniaturized mechanical switch to turn on touch-sensitive cells, offering a new method for controlling specific regions of the brain.
There are parallels between this breakthrough and another exciting branch of research focused on careful control of cells in the body, known as optogenetics. This technique involves inserting genes into otherwise regular calls to make them sensitive to light, allowing them to be stimulated for the purposes of treating paralysis, relieving pain and restoring vision.
Although there have been success stories, such as a case when optogenetics was used for partial vision restoration in a human for the first time last year, adapting the technology for clinical use has proven difficult due to the need for genetic modification of the cells. The UCL team has come up with another way of controlling brain activity that doesn't involve such measures.
"Our new technology uses magnetic particles and magnets to remotely and precisely control brain cell activity and, importantly, does this without introducing any device or foreign gene into the brain," said lead researcher Dr Yichao Yu.
The team's magnet-centric approach involves targeting brain cells called astrocytes, which live between the brain's blood vessels and nerve cells and supply neurons with metabolic and structural support, while also regulating activity of neuronal circuits. Conveniently for the scientists, they also happen to be touch-sensitive.
"Because astrocytes are sensitive to touch, decorating them with magnetic particles means you can give the cells a tiny prod from outside the body using a magnet, and as such, control their function," said senior author, Professor Mark Lythgoe. "This ability to remotely control astrocytes provides a new tool for understanding their function and may have the potential to treat brain and mood disorders, including depression."